The iCubate iC-GPC Assay™ is a multiplexed, in vitro diagnostic test for the rapid detection and identification of potentially pathogenic gram positive bacteria, which may cause bloodstream infection (BSI). Traditional culture techniques may require 2-4 days to identify both the causative organism and resistance profile, resulting in delayed treatment and increased costs. The iC-GPC Assay™ provides bacterial identification and resistance determination from positive blood cultures up to 48 hours faster than conventional methods, improving time to treatment and patient outcomes. The iC-GPC Assay™ detects five of the most common gram positive organisms associated with BSI as well as three clinically significant resistance markers:
|Bacterial Species||Resistance Markers|
|mecA– associated with methicillin resistance
vanA- associated with vancomycin resistance
vanB– associated with vancomycin resistance
Join the iCubate community for the latest updates!